TISAGENLECLEUCEL FOR RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN A PATIENT WITH A CHEK2 MUTATION

被引：0
|
作者：
Ipe, Abraham [1 ]
Angiolillo, Anne [1 ]
Wills, Melissa [1 ]
Wyche, Erica [1 ]
Webb, Jennifer [1 ]
Cheng, Jinjung [1 ]
Jacobsohn, David [1 ]
Bornhorst, Miriam [1 ]
Turner, Joyce [1 ]
Vatsayan, Anant [1 ]
机构：
[1] Childrens Natl Hosp, Washington, DC USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
541
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Case report: Tisagenlecleucel for treatment of relapsed B- acute lymphoblastic leukemia in a patient with CHEK2 mutation
    Ipe, Abraham
    Angiolillo, Anne
    Jacobsohn, David
    Cheng, Jinjun
    Bornhorst, Miriam
    Turner, Joyce
    Vatsayan, Anant
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [2] Common clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline CHEK2 variant
    Bazinet, Alexandre
    Heath, John
    Chong, Anne-Sophie
    Simo-Cheyou, Estelle R.
    Worme, Samantha
    Polo, Barbara Rivera
    Foulkes, William D.
    Caplan, Stephen
    Johnson, Nathalie A.
    Orthwein, Alexandre
    Mercier, Francois E.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2021, 7 (03):
  • [3] Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemia
    Leahy, Allison Barz
    Elgarten, Caitlin W.
    Grupp, Stephan A.
    Maude, Shannon L.
    Teachey, David T.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (10) : 959 - 971
  • [4] Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia
    Si Lim, Stephanie J.
    Grupp, Stephen A.
    DiNofia, Amanda M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [5] Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
    Mueller, Karen Thudium
    Grupp, Stephan A.
    Maude, Shannon L.
    Levine, John E.
    Pulsipher, Michael A.
    Boyer, Michael W.
    August, Keith J.
    Myers, G. Doug
    Tam, Constantine S.
    Jaeger, Ulrich
    Foley, Stephen Ronan
    Borchmann, Peter
    Schuster, Stephen J.
    Waller, Edmund K.
    Awasthi, Rakesh
    Potthoff, Bernd
    Warren, Andy
    Waldron, Edward R.
    McBlane, Fraser
    Chassot-Agostinho, Andrea
    Laetsch, Theodore W.
    BLOOD ADVANCES, 2021, 5 (23) : 4980 - 4991
  • [6] Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia
    Mueller, Karen Thudium
    Waldron, Edward
    Grupp, Stephan A.
    Levine, John E.
    Laetsch, Theodore W.
    Pulsipher, Michael A.
    Boyer, Michael W.
    August, Keith J.
    Hamilton, Jason
    Awasthi, Rakesh
    Stein, Andrew M.
    Sickert, Denise
    Chakraborty, Abhijit
    Levine, Bruce L.
    June, Carl H.
    Tomassian, Lori
    Shah, Sweta S.
    Leung, Mimi
    Taran, Tetiana
    Wood, Patricia A.
    Maude, Shannon L.
    CLINICAL CANCER RESEARCH, 2018, 24 (24) : 6175 - 6184
  • [7] The Feasibility, Safety, and Early Response of Tisagenlecleucel Therapy for Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Gocho, Yoshihiro
    Sakaguchi, Hirotoshi
    Iguchi, Akihiro
    Nishimura, Nao
    Uchiyama, Toru
    Deguchi, Takao
    Kato, Motohiro
    Tomizawa, Daisuke
    Onodera, Masafumi
    Matsumoto, Kimikazu
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [8] FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
    O'Leary, Maura C.
    Lu, Xiaobin
    Huang, Ying
    Lin, Xue
    Mahmood, Iftekhar
    Przepiorka, Donna
    Gavin, Denise
    Lee, Shiowjen
    Liu, Ke
    George, Bindu
    Bryan, Wilson
    Theoret, Marc R.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1142 - 1146
  • [9] Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia
    Thota, Swapna
    Advani, Anjali
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (05) : 425 - 434
  • [10] CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
    Vairy, Stephanie
    Garcia, Julia Lopes
    Teira, Pierre
    Bittencourt, Henrique
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3885 - 3898
12345